Exchange: NASDAQ·Updated 07:30 PM EDT
INAB logo

INAB IN8bio Inc

$1.10
$0.04
(3.51%)
Today
Closed $1.10
$0.00
(0.00%)
After Hours
Reported EarningsAug 6
Mkt Cap$11.24M
Vol22,606.00

About INAB

IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates for solid and liquid tumors and gamma-delta T cell engagers for cancer and autoimmune diseases. The company was founded by Lawrence S. Lamb and William T. Ho on February 8, 2016 and is headquartered in New York, NY.
45

Neutral Sentiment

How do you feel about INAB?

Advertisement|Remove ads.